Answers are grounded in this paper and cite their sources.
As the prevalence of chronic and communicable diseases increases, there has been an enhanced need for sensitive, rapid, reliable, and minimally invasive diagnostic technologies for monitoring disease progression and therapeutic effectiveness. Multifunctional nanomaterial-based electrochemical biosensors are emerging as powerful analytical tools due to their high sensitivity, selectivity, portability, and potential for real-time biomolecule detection. The purpose of this review is to shed light on the key underlying principles, nanomaterial engineering strategies, sensing principles, medical applications, and therapeutic assessment functionality of advanced electrochemical biosensors. Throughout the review, the merits of metallic nanoparticles, metal oxides, carbon nanotubes, graphene, MXenes, metal-organic frameworks, conducting polymers, and hybrid nanomaterials in increasing electrode conductivity, electroactive surface area, biomolecule immobilization, electron transfer kinetic, and electrochemical signal enhancement will be highlighted. This review delves deeper into the potential uses of sensors in identifying and tracking the processes of cancer, diseases of the cardiovascular system, diabetes, infections, problems in the nervous system, and cases of inflammation. It thoroughly discusses the role of drug monitoring, pharmacokinetics, and the potential uses of electrochemical sensors in providing ongoing monitoring of drugs in the human body. In addition, advancements in devices that are wearable and implantable, implement multiplexing, microfluidic principles, and artificial intelligence in biosensing are considered in the aspect of personal health and health care. Despite a multitude of technological improvements still present issues of biofouling, toxicity of nanomaterial, stability of biosensors, reproducibility, interference, calibration, mass production, and certification which makes it impossible to translate it into the practices of functional medicine.
No takes yet. Share an insight, caveat, or question.
Kumar Rajiv (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: